InsidersTradesSigma
申报总数
公司
▲ 买入（2 笔）
▼ 卖出（1 笔）
内部人交易记录
首席执行官已披露买入
2
已披露卖出
1
T+90 胜率
50%
T+90 平均收益
-21.2%
基于 2 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Browse the detailed record of transactions filed by Etherington Robert Dee, 董事长兼首席执行官. Insider active across 1 company, notably Clene Inc.. In total, 5 filings have been recorded. Breakdown: 2 buys · 1 sell. Total volume traded: €170k. History available since 30 June 2021. The latest transaction was disclosed on 30 September 2024 (Acquisition). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Etherington Robert Dee
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报5 总计
10,000 股@ US$4.7517.3% 占其流量Common StockSEC:0001562180-24-007036:0
标准退出：2024年12月29日 (T+90)
27,320 股@ US$3.0030.8% 占其流量Common StockSEC:0001562180-24-005867:0
25,000 股@ US$0.817.5% 占其流量Common StockSEC:0001562180-23-005506:0
标准退出：2023年9月24日 (T+90)
23,483 股@ US$4.7244.4% 占其流量Common StockSEC:0001562180-22-005708:0
80,076 股0Common StockSEC:0001562180-21-004605:0
5 条申报中的 5 条
About Etherington Robert Dee
Robert Dee Etherington is the Chief Executive Officer of Clene Inc. He leads the company in the biotechnology sector, focusing on the development of innovative treatments. With a strong background in the industry, Robert Dee Etherington is responsible for the overall strategy and operational direction of the company.
